Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nuno Taveira

Showing results (21-30 of 88) with videos related to

Pageof 9
Sort By:
Journal of Virology|November 1, 2016
A Helical Short-Peptide Fusion Inhibitor with Highly Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency VirusShengwen Xiong, Pedro Borrego, Xiaohui Ding, et al.
Plos One|October 5, 2011
Origin and epidemiological history of HIV-1 CRF14_BGInês Bártolo, Ana B Abecasis, Pedro Borrego, et al.
Virology|April 23, 2003
Serum immunoglobulin A (IgA)-mediated immunity in human immunodeficiency virus type 2 (HIV-2) infectionQin Lizeng, Pia Skott, Samer Sourial, et al.
Diagnostics (Basel, Switzerland)|March 6, 2021
Diagnosis of SARS-Cov-2 Infection by RT-PCR Using Specimens Other Than Naso- and Oropharyngeal Swabs: A Systematic Review and Meta-AnalysisVânia M Moreira, Paulo Mascarenhas, Vanessa Machado, et al.
Journal of Clinical Microbiology|February 12, 2010
Outbreak of acute respiratory infection among infants in Lisbon, Portugal, caused by human adenovirus serotype 3 and a new 7/3 recombinant strainHelena Rebelo-de-Andrade, Cristiana Pereira, Marta Gíria, et al.
Journal of Clinical Microbiology|February 4, 2006
Use of a new dual-antigen enzyme-linked immunosorbent assay to detect and characterize the human antibody response to the human immunodeficiency virus type 2 envelope gp125 and gp36 glycoproteinsJosé Maria Marcelino, Helena Barroso, Fátima Gonçalves, et al.
Plos One|December 6, 2014
HIV-1 diversity, transmission dynamics and primary drug resistance in AngolaInês Bártolo, Suzana Zakovic, Francisco Martin, et al.
ACS Applied Materials & Interfaces|September 21, 2018
Noncovalent PEG Coating of Nanoparticle Drug Carriers Improves the Local Pharmacokinetics of Rectal Anti-HIV MicrobicidesRute Nunes, Francisca Araújo, Luisa Barreiros, et al.
AIDS Research and Human Retroviruses|August 4, 2018
Accidental Father-to-Son HIV-1 Transmission During the Seroconversion PeriodIfeanyi Ezeonwumelu, Inês Bártolo, Francisco Martin, et al.
AIDS Research and Human Retroviruses|September 10, 2011
Genetic diversity and drug resistance profiles in HIV type 1- and HIV type 2-infected patients from Cape Verde IslandsVânia Oliveira, Inês Bártolo, Pedro Borrego, et al.
Pageof 9

Showing results (21-30 of 88) with videos related to

Sort By:
Pageof 9
Journal of Virology|November 1, 2016
A Helical Short-Peptide Fusion Inhibitor with Highly Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency VirusShengwen Xiong, Pedro Borrego, Xiaohui Ding, et al.
Plos One|October 5, 2011
Origin and epidemiological history of HIV-1 CRF14_BGInês Bártolo, Ana B Abecasis, Pedro Borrego, et al.
Virology|April 23, 2003
Serum immunoglobulin A (IgA)-mediated immunity in human immunodeficiency virus type 2 (HIV-2) infectionQin Lizeng, Pia Skott, Samer Sourial, et al.
Diagnostics (Basel, Switzerland)|March 6, 2021
Diagnosis of SARS-Cov-2 Infection by RT-PCR Using Specimens Other Than Naso- and Oropharyngeal Swabs: A Systematic Review and Meta-AnalysisVânia M Moreira, Paulo Mascarenhas, Vanessa Machado, et al.
Journal of Clinical Microbiology|February 12, 2010
Outbreak of acute respiratory infection among infants in Lisbon, Portugal, caused by human adenovirus serotype 3 and a new 7/3 recombinant strainHelena Rebelo-de-Andrade, Cristiana Pereira, Marta Gíria, et al.
Journal of Clinical Microbiology|February 4, 2006
Use of a new dual-antigen enzyme-linked immunosorbent assay to detect and characterize the human antibody response to the human immunodeficiency virus type 2 envelope gp125 and gp36 glycoproteinsJosé Maria Marcelino, Helena Barroso, Fátima Gonçalves, et al.
Plos One|December 6, 2014
HIV-1 diversity, transmission dynamics and primary drug resistance in AngolaInês Bártolo, Suzana Zakovic, Francisco Martin, et al.
ACS Applied Materials & Interfaces|September 21, 2018
Noncovalent PEG Coating of Nanoparticle Drug Carriers Improves the Local Pharmacokinetics of Rectal Anti-HIV MicrobicidesRute Nunes, Francisca Araújo, Luisa Barreiros, et al.
AIDS Research and Human Retroviruses|August 4, 2018
Accidental Father-to-Son HIV-1 Transmission During the Seroconversion PeriodIfeanyi Ezeonwumelu, Inês Bártolo, Francisco Martin, et al.
AIDS Research and Human Retroviruses|September 10, 2011
Genetic diversity and drug resistance profiles in HIV type 1- and HIV type 2-infected patients from Cape Verde IslandsVânia Oliveira, Inês Bártolo, Pedro Borrego, et al.
Pageof 9